Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism.

ABSTRACT:

Background

Clinical practice guidelines recommend that patients with incidental venous thromboembolism (VTE) receive the same anticoagulant therapy as those with symptomatic VTE. We aimed to compare the rate of complications between cancer patients with incidental and symptomatic VTE through a long-term follow-up cohort.

Methods

We performed a post hoc analysis of prospective studies of cancer patients with VTE between 2008 and 2019, with the primary outcome of rates of recurrent VTE and clinically relevant bleeding (CRB) in incidental and symptomatic VTE groups.

Results

In total, 796 patients were included, of which 42.8% had incidental VTE. No significant differences were noted in the rate of recurrent VTE (0.4 per 100 patients/month vs. 0.5 per 100 patients/

SUBMITTER: Barca-Hernando M 

PROVIDER: S-EPMC10237269 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature